Latest Legal News | Orlando Legal Examiner

Pesticides and Birth Defects

There’s a major problem in the agricultural fields of Florida. Yet, it goes practically unnoticed because those affected are migrant farmworkers who often don’t speak much English. They pick our strawberries and tomatoes. They provide back breaking labor for sub standard wages. They often live in ra

By The Legal Examiner

/ 25 May 2006

Wyeth's Fen-Phen Settlement Approved

Drug maker Wyeth is expected to announce as early as today that a revised legal settlement, covering the most common damage claims for the diet drugs it once sold, has won final judicial approval. About 5.8 million people took Wyeth’s drugs Redux or Pondimin before they were removed from the market

By The Legal Examiner

/ 24 May 2006

In Public Relations World It's Botch & Lomb

There’s an interesting article published in Advertising Ageabout how Bausch & Lomb botched the crisis surrounding its $500 million contact lens solution products market. In spite of a public relations blitz in which the company took out full page advertisements in 12 major daily newspapers, Bausch &

By The Legal Examiner

/ 23 May 2006

FDA Urges Stronger Warning for Ketek

Citing a growing number of deaths related to liver failure, the FDA has called for a stronger warning label for the antibiotic drug KetekThe FDA has received reports of 12 cases of acute liver failure, including the four deaths, in patients treated with Ketek, according to a copy of an FDA memo. FDA

By The Legal Examiner

/ 23 May 2006

Fosamax Linked to Serious Injury

While physicians say they’re rare, Fosamax users can be susceptible to “dead jaw” disease or commonly known as jaw rot. Fosamax, an osteoporosis drug belonging to the bisphosphonate family, can lead to “dead jaw” syndrome — a painful condition that causes ulcers, tooth loss and exposed bone. But whi

By The Legal Examiner

/ 22 May 2006

U of Pitt Med Center Doc Finds Fusarium in Bausch & Lomb Product

As part of the CDC’s investigation of Bausch & Lomb’s eye contact solution ReNu with MoistureLoc, a University of Pittsburgh Medical Center doctor was able to grow the fusarium keratitis fungus from the contact lens solution. Dr. Deepinder Dhaliwal, the Director of Refractive Surgery at UPMC found t

By The Legal Examiner

/ 19 May 2006

Ketek Facing the Heat

US Senate Finance Committee Chairman Charles Grassley (R-IA) has called on the maker of Ketek, Sanofi-Aventis, to produce its investigator as part of a probe of the company’s handling of the antibiotic. The letter released last night by Mr. Grassley, an Iowa Republican, is the second one he has sent

By The Legal Examiner

/ 18 May 2006

FDA: Bausch & Lomb Failed to Promptly Notify

The FDA said yesterday that ReNu maker Bausch & Lomb failed to promptly report 35 cases of the fusarium keratitis infection. The failure to inform the FDA within a 30 day time period is part of a larger list of 20 violations the FDA listed after inspecting the Greensville, SC plant.

By The Legal Examiner

/ 17 May 2006

More News on Bausch & Lomb

I was quoted in today’s Boston Globe as a result of Bausch & Lomb’s decision to halt permanently the worldwide sales of its ReNu with MoistureLoc. As the paper stated, I think the decision confirms what we’ve suspected all along, namely, that the problem lies in the solution itself.

By The Legal Examiner

/ 16 May 2006

Bausch & Lomb Hasn't Removed ReNu with MultiPlus

In spite of a sharp increase in fungal infections among users of ReNu with MultiPlus, Bausch & Lomb has not removed the eye contact solution product from store shelves. US health officials have now confirmed more than 120 cases of a potentially blinding eye infection that may be related to contact l

By The Legal Examiner

/ 15 May 2006

Vioxx Risks Continue Even After Its Use is Discontinued

A new Merck & Co. study reveals that risk for heart attacks and strokes continues even when its use is discontinued. This risk continues for a year after use. In spite of the new study, Merck says it won’t change its litigation strategy. Oh well, why be confused with the facts.

By The Legal Examiner

/ 12 May 2006

Frivolous Lawsuits a Fiction

A new research study appearing in the May 11th New England Journal of Medicine, refutes the oft-mentioned claim by some that frivolous lawsuits, especially medical malpractice claims lack merit. For this study, which appears in the May 11 New England Journal of Medicine, a panel of trained physician

By The Legal Examiner

/ 11 May 2006